Heart failure is associated with significant mortality and morbidity in India and is amongst the leading causes of mortality and morbidity in India in spite of current management options. Patients with pre-existing cardiovascular co-morbidities appear to be at a higher risk for mortality from COVID-19.1 Thus, we believe it is all the more important to exchange knowledge and urgency to ACT on Heart Failure. In this regard, AstraZeneca and Docplexus have organized an interactive webinar on 3rd May 2020 at 6:00 PM. In this webinar session, Dr. Rajeev Agarwal , Dr.
Saumitra Ray , and Dr. JC Mohan will talk about "Heart Failure in India: Experts view on the Dilemmas in HF Management" and Dr. Uday Jadhav will moderate the post-webinar panel discussion. Agenda: We invite you to submit your questions which will be answered by the speakers at the end of the session.
